Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
The Annals of Pharmacotherapy
|
May 27, 2023
Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
Daniel C Malone, Ainhoa Gómez-Lumbreras, Richard D Boyce, et al.
American Journal of Medical Genetics. Part A
|
May 29, 2026
Assessment of Growth in Cardio-Facio-Cutaneous Syndrome
Kari Johnston, Sandesh C S Nagamani, Bradley S Miller, et al.
International Journal of Medical Informatics
|
March 31, 2022
Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions
Henrik Thiess, Guilherme Del Fiol, Daniel C Malone, et al.
Journal of Biomedical Semantics
|
January 29, 2013
Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness
Richard D Boyce, John R Horn, Oktie Hassanzadeh, et al.
Journal of Biomedical Informatics
|
March 18, 2023
Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions
Sanya B Taneja, Tiffany J Callahan, Mary F Paine, et al.
Drug Safety
|
April 11, 2020
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin
Lorenzo Villa Zapata, Philip D Hansten, John R Horn, et al.
JAMIA Open
|
March 25, 2021
Designing and evaluating contextualized drug-drug interaction algorithms
Eric Chou, Richard D Boyce, Baran Balkan, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Plos One
|
October 21, 2016
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
Matthias Samwald, Hong Xu, Kathrin Blagec, et al.
Studies in Health Technology and Informatics
|
June 8, 2022
Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review
Lorenzo Villa Zapata, Vignesh Subbian, Richard D Boyce, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
The Annals of Pharmacotherapy
|
May 27, 2023
Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
Daniel C Malone, Ainhoa Gómez-Lumbreras, Richard D Boyce, et al.
American Journal of Medical Genetics. Part A
|
May 29, 2026
Assessment of Growth in Cardio-Facio-Cutaneous Syndrome
Kari Johnston, Sandesh C S Nagamani, Bradley S Miller, et al.
International Journal of Medical Informatics
|
March 31, 2022
Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions
Henrik Thiess, Guilherme Del Fiol, Daniel C Malone, et al.
Journal of Biomedical Semantics
|
January 29, 2013
Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness
Richard D Boyce, John R Horn, Oktie Hassanzadeh, et al.
Journal of Biomedical Informatics
|
March 18, 2023
Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions
Sanya B Taneja, Tiffany J Callahan, Mary F Paine, et al.
Drug Safety
|
April 11, 2020
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin
Lorenzo Villa Zapata, Philip D Hansten, John R Horn, et al.
JAMIA Open
|
March 25, 2021
Designing and evaluating contextualized drug-drug interaction algorithms
Eric Chou, Richard D Boyce, Baran Balkan, et al.
Pharmacology Research & Perspectives
|
December 25, 2024
Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System
Maryann R Chapin, Sandra L Kane-Gill, Xiaotong Li, et al.
Plos One
|
October 21, 2016
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
Matthias Samwald, Hong Xu, Kathrin Blagec, et al.
Studies in Health Technology and Informatics
|
June 8, 2022
Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review
Lorenzo Villa Zapata, Vignesh Subbian, Richard D Boyce, et al.
Page
of 10